Buscar

01/11/2025 Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group
Brandao, M, Prisciandaro, E, Xenophontos, E, Mariolo, A, Sadeghi, AH, Filippi, AR, Levy, A, Bandura, A, Caramella, C, Dickhoff, C, de Margerie-Mellon, C, Faivre-Finn, C, Portik, D, Sanchez-Lorente, D, De Ruysscher, D, Smit, E, Gobbini, E, Fadel, E, Ruffini, E, Olmetto, E, Cortiula, F, Bahce, I, Houda, I, Opitz, I, Naidoo, J, Edwards, J, Remon, J, Benitez, JC, Trujillo, JC, Derks, J, Amrane, K, Hartemink, KJ, Stathopoulos, K, Hendriks, LEL, Iglesias, M, Occhipinti, M, Guckenberger, M, Levra, NG, Girard, N, Reguart, N, Mercier, O, Bironzo, P, Hofman, P, Petersen, RH, De Angelis, R, Abgral, R, Terrisse, S, Popat, S, Pierret, T, Blum, TG, Ricardi, U, Dionisi, V, Berghmans, T, Dingemans, AMC. Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group. LUNG CANCER. 2025; 209DOI:10.1016/j.lungcan.2025.108798. PMID:41108881. IF:4.400(Q1/2D).
01/12/2025 Beyond Contraception: Exploring Health Benefits of Short-Acting Reversible Contraceptives-A Narrative Review
Perello-Capo, J, Quílez-Conde, JC, Calaf-Alsina, J. Beyond Contraception: Exploring Health Benefits of Short-Acting Reversible Contraceptives-A Narrative Review. WOMENS HEALTH REPORTS. 2025; 6(1)DOI:10.1177/26884844251405066. PMID:. IF:(Q/D).
01/10/2025 Proficiency in Laparoscopic Training: online versus Onsite Suturing Courses
Argay, I, Schettini, G, Giorgi, M, Habib, N, Rovira, R, Wattiez, A, Amro, B, Varbiro, S, Centini, G. Proficiency in Laparoscopic Training: online versus Onsite Suturing Courses. JSLS-Journal of the Society of Laparoendoscopic Surgeons. 2025; 29(4)DOI:10.4293/JSLS.2025.00084. PMID:41438213. IF:1.800(Q2/5D).
30/04/2025 CD200 in acute myeloid leukemia: marked upregulation in CEBPA biallelic mutated cases
González-Guerrero, L, Castellet, H, Martinez, Clara, González, N, Guijarro, F, Lloveras, N, Pratcorona, M, Gich, I, Berenguer-Molins, P, Perera-Bel, J, Zamora, L, Mascaró, M, Sampol, A, Garcia-Guiñón, A, Vives, S, Tormo, M, Arnan, M, Villamor, N, Nomdedéu, JF. CD200 in acute myeloid leukemia: marked upregulation in CEBPA biallelic mutated cases. Diagnostic Pathology. 2025; 20(1)DOI:10.1186/s13000-025-01655-w. PMID:40307896. IF:2.300(Q2/5D).